SPERA NEXUS, Inc.

Booth No.：6C-22

Category：Ingredients

Company Information

Email： tamegai.hi@spera-nexus.co.jp TEL： +81-3-3279-0545 Address： 1030023
4-8-2, Nihombashi. Honcho, Chuo-ku, Tokyo JAPAN URL： https://www.spera-nexus.co.jp/

Contact in Japan

Japan agent：営業部

We “SPERA NEXUS” started the operation from 2021 by integration of “Iwaki” Pharmaceutical Chemicals Division and “Iwaki Seiyaku” Fine Chemicals Division”. We can archive crystalline evaluation, process optimization, commercial manufacturing and procurement of APIs and intermediates by own manufacturing and import. In 2023, our high-potency substance manufacturing facility started the operation.
We always think and act from the perspective of total optimization and always provide new value by improving our technology and quality of the service.

Company information

Address	1030023 4-8-2, Nihombashi. Honcho, Chuo-ku, Tokyo JAPAN
TEL	+81-3-3279-0545
URL	https://www.spera-nexus.co.jp/
Email	tamegai.hi@spera-nexus.co.jp

Product Classification	Apremilast Imatinib Mesilate Ezetimibe Edoxaban tosilate hydrate Olopatadine hydrochloride Canagliflozin hydrate Carfilzomib Guanfacine hydrochloride Zonisamide Zolpidem Tartrate Teneligliptin hydrobromide hydrate Nintedanib ethanesulfonate Pazopanib hydrochloride Paliperidone palmitate Bilastine Finasteride Pemafibrate Venlafaxine hydrochloride Macitentan Mirabegron

Contact in Japan

Japan Agent	営業部

Product introduction

ApremilastImatinib MesilateEzetimibeEdoxaban tosilate hydrateOlopatadine hydrochlorideCanagliflozin hydrateCarfilzomibGuanfacine hydrochlorideZonisamideZolpidem TartrateTeneligliptin hydrobromide hydrateNintedanib ethanesulfonatePazopanib hydrochloridePaliperidone palmitateBilastineFinasteridePemafibrateVenlafaxine hydrochlorideMacitentanMirabegron

Sharing Exhibitor

SPERA PHARMA, Inc.(JAPAN)